Evidence map›Paper›PMID 40994964›Full record

ArticleFrontiers in oncology2025

Epidemiological characteristics and risk factors of high-risk HPV infection, cervical cancer, and precancerous lesions among women in Southwestern China.

Lu Zhang, Qiwen Zhang, Bing Pang, Zhuo Tan, Denghui Yang, Jieru Peng, Yao Dong, Xia Wu, Liu Yang, Youlin Qiao and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lu Zhang *Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Qiwen Zhang *Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Bing PangDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhuo TanDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Denghui YangDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Jieru PengDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Yao DongDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Xia WuHealthcare Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Liu YangHealthcare Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Youlin QiaoChinese Academy of Medical Sciences, and Peking Union Medical College, School of Population Medicine and Public Health, Beijing, China.
Chunxia YangDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer poses a significant threat to women's reproductive and overall health. In Chengdu, southwestern China, free cervical cancer screening is provided to women in both urban and suburban areas, using high-risk human papillomavirus (HR-HPV) testing combined with cytology triage. This study aimed to investigate the epidemiological characteristics and risk factors of HR-HPV infection, cervical cancer, and high-grade precancerous lesions based on large-scale screening data from Chengdu. Methods: This retrospective study analyzed cervical cancer screening data from January 1, 2021, to December 31, 2022, in Chengdu. A total of 107,120 women aged 35-64 years who underwent screening with HR-HPV testing combined with cytology triage were included. Screening participation and detection outcomes were analyzed to evaluate program implementation and to describe the distribution of HR-HPV and cervical lesions. Multivariable logistic regression was performed to identify factors independently associated with HR-HPV infection and cervical cancer/precancerous lesions. Results: The overall prevalence of HR-HPV infection was 10.54%, with HPV 16/18 accounting for 1.26%. The crude detection rate of cervical cancer and high-grade precancerous lesions (≥ HSIL/CIN2-3) was 399.55 per 100,000, of which the detection rate of cervical cancer was 19.60 per 100,000. The early diagnosis rate through screening reached 97.66%. The distribution of HPV 16/18 and other HR-HPV types varied across different cervical lesion groups, with HPV 16/18 being the predominant types associated with cervical cancer. Multivariable logistic regression analysis showed that age ≥55 years (55-59 years: aOR=1.34, 95% CI: 1.22-1.47; 60-64 years: aOR=1.53, 95% CI: 1.37-1.73), residence in suburban areas (aOR=1.19, 95% CI: 1.11-1.27), menopause (aOR=1.08, 95% CI: 1.01-1.15), having three or more childbirths (aOR=1.18, 95% CI: 1.06-1.31), and three or more abortions (aOR=1.16, 95% CI: 1.06-1.26) were associated with a higher risk of HR-HPV infection. In contrast, later age at first birth (21-25 years: aOR=0.88, 95% CI: 0.83-0.94; ≥26 years: aOR=0.80, 95% CI: 0.74-0.86) and condom use (aOR=0.87, 95% CI: 0.82-0.92) were protective factors. Additionally, age (55-59 years: aOR=1.57, 95% CI: 1.03-2.41), residential areas (suburban areas: aOR=1.82, 95% CI: 1.23-2.69), and menopausal status (yes or uncertainty: aOR=0.72, 95% CI: 0.52-0.99) were also associated with cervical cancer and precancerous lesions. A potential interaction between age and menopausal status was also observed. Conclusion: This study characterized the epidemiology of HR-HPV infection, cervical cancer, and high-grade precancerous lesions in Chengdu and identified associated risk and protective factors, providing evidence to inform targeted screening and prevention strategies.

Indexed as

cervical cancerepidemiologyhuman papillomavirus infectionrisk factorscreening

Identifiers

PMID40994964
PMCPMC12454022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.